Luxury electric car manufacturer Lucid (NASDAQ:LCID) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 29.3% ...

Lucid Group announces second-quarter financial results Tuesday after the bell. Here's a rundown of the electric vehicle maker ...

Rivian largely blamed a tapering in the value of U.S. regulatory credits - expected to be about half of the $300 million it ...

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that ...

Live Updates Live Coverage Updates appear automatically as they are published. How Lucid Performed After Recent Earnings 1:00 ...

US stock futures wavered amid a tough batch of corporate earnings after the bell and persistent trade uncertainty.

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) announced that its Australian subsidiary has received the clinical study report for a Phase 1 multiple ...

Quantum Biopharma Ltd. (NASDAQ:QNTM) announced on Tuesday that its subsidiary Huge Biopharma Australia has received the ...

Lucid Group (LCID) delivered earnings and revenue surprises of -27.27% and +2.37%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Dr. Lakshmi P. Kotra, Director at Quantum BioPharma and Professor at University of Toronto, who led the discovery of Lucid-MS, added that the company is preparing to launch efficacy trials in patients ...

Detailed price information for Lucid Group Inc (LCID-Q) from The Globe and Mail including charting and trades.